American Association for the Advancement of Science, Science Translational Medicine, 503(11), 2019
DOI: 10.1126/scitranslmed.aaw4993
Full text: Unavailable
The androgen receptor (AR) regulates mRNA-specific translation through 4EBP1, which is a druggable vulnerability in AR-deficient prostate cancer.